Page last updated: 2024-10-30

ketotifen and Retinitis

ketotifen has been researched along with Retinitis in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Retinitis: Inflammation of the RETINA. It is rarely limited to the retina, but is commonly associated with diseases of the choroid (CHORIORETINITIS) and of the OPTIC DISK (neuroretinitis).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Kozak, Y1
Sakai, J1
Sainte-Laudy, J1
Faure, JP1
Benveniste, J1

Other Studies

1 other study available for ketotifen and Retinitis

ArticleYear
Pharmacological modulation of IgE-dependent mast cell degranulation in experimental autoimmune uveoretinitis.
    Japanese journal of ophthalmology, 1983, Volume: 27, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Cromolyn Sodium; Hypersensitivity, Immediate

1983